AXNX Aug 2024 67.500 call
| Previous close | 1.6000 |
| Open | N/A |
| Bid | 0.2000 |
| Ask | 5.0000 |
| Strike | 67.50 |
| Expiry date | 2024-08-16 |
| Day's range | 1.6000 - 1.6000 |
| Contract range | N/A |
| Volume | |
| Open interest | 1 |
Insider MonkeyArtisan Small Cap Fund Exited Axonics (AXNX) on an Acquisition Announcement
Artisan Partners, an investment management company, released its “Artisan Small Cap Fund” first quarter 2024 investor letter. A copy of the letter can be downloaded here. Equity markets surged at the beginning of 2024 in anticipation of the US economy entering a “goldilocks” scenario – a soft landing combined with decreasing inflation, potentially leading to […]
Business WireAxonics Receives Regulatory Approval for Recharge-Free SNM System in Australia
IRVINE, Calif., May 16, 2024--Axonics, Inc. (Nasdaq: AXNX) today announced that it has received regulatory approval from the Therapeutic Goods Administration (TGA) for marketing the Axonics F15™ recharge-free sacral neuromodulation (SNM) system in Australia to treat adults with overactive bladder.
Business WireAxonics Reports First Quarter 2024 Financial Results
IRVINE, Calif., April 30, 2024--Axonics, Inc. (Nasdaq: AXNX), a medical technology company that develops and commercializes innovative and minimally invasive products to treat bladder and bowel dysfunction, today reported financial results for the three months ended March 31, 2024.
